BRPI0608217A2 - método para síntese de rotulação de complexo de gálio radiorrotulado, complexo de gálio radiorrotulado, e, método para formação de imagem de superexpressão de egfr em tumores - Google Patents

método para síntese de rotulação de complexo de gálio radiorrotulado, complexo de gálio radiorrotulado, e, método para formação de imagem de superexpressão de egfr em tumores

Info

Publication number
BRPI0608217A2
BRPI0608217A2 BRPI0608217A BRPI0608217A BRPI0608217A2 BR PI0608217 A2 BRPI0608217 A2 BR PI0608217A2 BR PI0608217 A BRPI0608217 A BR PI0608217A BR PI0608217 A BRPI0608217 A BR PI0608217A BR PI0608217 A2 BRPI0608217 A2 BR PI0608217A2
Authority
BR
Brazil
Prior art keywords
gallium complex
radiolabelled
radiolabelled gallium
tumors
synthesis
Prior art date
Application number
BRPI0608217A
Other languages
English (en)
Inventor
Asa Liljegren Sundberg
Bengt Langstrom
Irina Velikyan
Vladimir Tolmachev
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of BRPI0608217A2 publication Critical patent/BRPI0608217A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0608217A 2005-02-22 2006-02-21 método para síntese de rotulação de complexo de gálio radiorrotulado, complexo de gálio radiorrotulado, e, método para formação de imagem de superexpressão de egfr em tumores BRPI0608217A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65513905P 2005-02-22 2005-02-22
PCT/IB2006/000345 WO2006090232A2 (en) 2005-02-22 2006-02-21 Radiolabeled gallium complexes, methods for synthesis and use for pet imaging of egfr epxression in malignant tumors

Publications (1)

Publication Number Publication Date
BRPI0608217A2 true BRPI0608217A2 (pt) 2016-10-11

Family

ID=36927800

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0608217A BRPI0608217A2 (pt) 2005-02-22 2006-02-21 método para síntese de rotulação de complexo de gálio radiorrotulado, complexo de gálio radiorrotulado, e, método para formação de imagem de superexpressão de egfr em tumores

Country Status (12)

Country Link
US (2) US20060188441A1 (pt)
EP (1) EP1850881A2 (pt)
JP (1) JP2008531988A (pt)
KR (1) KR20070106731A (pt)
CN (1) CN101443051A (pt)
AU (1) AU2006217612A1 (pt)
BR (1) BRPI0608217A2 (pt)
CA (1) CA2598863A1 (pt)
MX (1) MX2007010116A (pt)
NO (1) NO20074576L (pt)
RU (1) RU2007131538A (pt)
WO (1) WO2006090232A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8926945B2 (en) * 2005-10-07 2015-01-06 Guerbet Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium
FR2899585B1 (fr) * 2006-04-05 2012-06-15 Guerbet Sa Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
FR2980193B1 (fr) * 2011-09-15 2014-02-14 Guerbet Sa Procede de purification de produits de contraste
JP6185262B2 (ja) * 2013-03-07 2017-08-23 日本メジフィジックス株式会社 核医学骨画像解析技術
GB201405591D0 (en) * 2014-03-28 2014-05-14 Ge Healthcare Ltd Heatseal
CN107405538B (zh) * 2015-01-30 2021-06-15 高级催化剂应用品国际有限公司 用于从来源于68Ge/68Ga发生器的洗脱物纯化Ga-68的工艺和用于所述工艺中的色谱柱
WO2021234741A1 (en) 2020-05-18 2021-11-25 C.M.S. S.P.A. Microwave device for the rapid labelling of in kit-formulated radiopharmaceuticals
JP2023157161A (ja) * 2022-04-14 2023-10-26 三菱重工航空エンジン株式会社 遮熱コーティングの施工方法及び耐熱部材
US20250289832A1 (en) * 2022-04-27 2025-09-18 Nihon Medi-Physics Co., Ltd. Method for producing radioactive metal complex

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4288424A (en) * 1979-01-15 1981-09-08 Massachusetts Institute Of Technology Generator for ionic gallium-68 based on column chromatography
US4330507A (en) * 1980-06-11 1982-05-18 New England Nuclear Corporation Method and system for generating and collecting gallium-68 using alkaline eluant
DK0436005T3 (da) * 1989-07-20 1995-07-03 Sandoz Ltd Mærkede polypeptidderivater
US5686410A (en) * 1989-07-20 1997-11-11 Novartis Ag Polypeptide derivatives
WO1993009816A1 (en) * 1991-11-14 1993-05-27 Battelle Memorial Institute Method for diagnosing and treating cancer
DE4231622C2 (de) * 1992-09-22 1996-09-05 Bakelite Ag Verfahren zur Herstellung von Metallneutralkomplexen mit hoher Koordinationszahl und deren Verwendung
US6071490A (en) * 1998-05-07 2000-06-06 Immunomedics, Inc. Position emission tomography using gallium-68 chelates
EP1389090A2 (en) * 2001-04-26 2004-02-18 Board of Regents, The University of Texas System Diagnostic imaging compositions, their methods of synthesis and use
GB0308408D0 (en) * 2003-04-11 2003-05-21 Amersham Plc Microwave activation
WO2004096254A2 (en) * 2003-05-02 2004-11-11 Xpression Antibody Therapeutics, Inc. Transferrin conjugates for tumor treatment
US20050085417A1 (en) * 2003-10-16 2005-04-21 Thomas Jefferson University Compounds and methods for diagnostic imaging and therapy

Also Published As

Publication number Publication date
WO2006090232A3 (en) 2007-04-05
CA2598863A1 (en) 2006-08-31
AU2006217612A1 (en) 2006-08-31
KR20070106731A (ko) 2007-11-05
MX2007010116A (es) 2007-10-12
US20060188441A1 (en) 2006-08-24
CN101443051A (zh) 2009-05-27
RU2007131538A (ru) 2009-03-27
NO20074576L (no) 2007-11-20
EP1850881A2 (en) 2007-11-07
WO2006090232A2 (en) 2006-08-31
US20110117012A1 (en) 2011-05-19
JP2008531988A (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
EG25847A (en) System and method for using time-distance characteristics in acquisition, processing and imaging of t-csfm data
LTC2100614I2 (lt) Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui
AP2881A (en) Enhanced systems and methods for re-induced hyperthermia II
HRP20171337T1 (hr) Monoklonska antitijela protiv klaudina-18 za liječenje karcinoma
ZA200803672B (en) Compositions and methods for treating tumors presenting survivin antigens
IL213116B (en) Antitumor combinations containing antibodies recognizing specifically cd38 and melphalan
EG25786A (en) Method for managing and localizing data
CR10667A (es) Compositions and methods for diagnosing and treating cancer
IL199989A (en) An antibody that inhibits the dimerization of her2 and its use in cancer treatment
PT3185012T (pt) Método para identificação, seleção e análise de células tumorais
IL192001A0 (en) Means and methods for mediating protein interference
PL2500360T3 (pl) Kompozycje i sposoby diagnozowania i leczenia nowotworu
EP1869629A4 (en) SYSTEM AND METHOD FOR OFFERING TRAVEL SERVICES
IL185501A0 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
DE602006014926D1 (de) Abbildungsvorrichtung, Abbildungsverfahren, Aufzeichnungsmedium und Programm
BRPI0822815A2 (pt) Método e aparelho para compressão de textura utilizando síntese de textura de amostragem baseada em patch
EP2015783A4 (en) METHOD FOR TESTING THE SENSITIVITY OF A MEDICINAL PRODUCT IN SOLID TUMORS BY QUANTIFYING THE EXPRESSION OF mRNA IN THIN CUTS OF TUMOR TISSUE
GB0712333D0 (en) Method for analyzing data having shared and distinct
BRPI0608217A2 (pt) método para síntese de rotulação de complexo de gálio radiorrotulado, complexo de gálio radiorrotulado, e, método para formação de imagem de superexpressão de egfr em tumores
EP1909854A4 (en) METHOD FOR TREATING CANCER
BRPI0817031A2 (pt) kit de diagnóstico e método para prognóstico de cancro em sujeitos mamíferos
IL198550A0 (en) Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis, corresponding compositions and kits
EP1934373A4 (en) SAVER PROTEIN AND RNA FOR THE DETECTION OF BREAST CANCER
IL180870A0 (en) Method for preparing n-aminopiperedine and its salts
FR2918996B1 (fr) Procede et kits de diagnostic et de pronostic de tumeurs endocrines, et en particulier de tumeurs de l'hypophyse

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 PAR 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B11Z Dismissal: petition dismissal - article 216, par 2 of industrial property law

Free format text: REFERENTE A PETICAO 20070115846 DE 20/08/2007

B11M Decision cancelled [chapter 11.13 patent gazette]

Free format text: O DESPACHO 11.6.1 DA RPI 2146 DE 22/02/2012 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.

B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: O DESPACHO 6.7 DA RPI 2100 DE 05/04/2011 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 8A, 9A, 10A E 11A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]